SGD Pharma announces its partnership with the Ompi Ez-fill® platform in order to offer sterile and depyrogenated vials to the parenteral market.

Eighteen months after the foundation stone of its French plant at Saint-Quentin-la-Motte (Somme region), SGD Pharma organized a grand opening for its fifth industrial site, dedicated to the pharmaceutical industry.

Greenfield to State-of-the-Art in 18 months:

Close to the historical site of Mers Les Bains, the plant represented a fourfold challenge for the company:

SGD has announced Alain Comel’s appointment as Chief Financial Officer for the future pharmaceutical entity.

Responsible for setting up the financial department of the new pharmaceutical entity, Alain Comel will be part of the Executive Committee and will support the growth’s strategy of the future entity.

SGD Group S.A.S. has become Cogent Glass Limited’s majority shareholder, India-based manufacturer of Type I molded and tubular glass vials for the pharmaceutical industry.